BTIG Research Forecasts Strong Price Appreciation for GE HealthCare Technologies (NASDAQ:GEHC) Stock

GE HealthCare Technologies (NASDAQ:GEHC) had its price objective boosted by investment analysts at BTIG Research from $87.00 to $91.00 in a research note issued on Wednesday, MarketBeat.com reports. The firm currently has a “buy” rating on the stock. BTIG Research’s price target would indicate a potential upside of 10.56% from the stock’s previous close.

A number of other equities analysts have also weighed in on GEHC. Evercore ISI reaffirmed an “outperform” rating and set a $95.00 target price on shares of GE HealthCare Technologies in a research report on Monday, January 5th. Morgan Stanley boosted their price target on shares of GE HealthCare Technologies from $74.00 to $80.00 and gave the company an “equal weight” rating in a research note on Thursday, October 30th. UBS Group lowered shares of GE HealthCare Technologies from a “neutral” rating to a “sell” rating and raised their price objective for the company from $73.00 to $77.00 in a research note on Thursday, January 15th. Wells Fargo & Company reduced their price objective on shares of GE HealthCare Technologies from $89.00 to $87.00 and set an “overweight” rating for the company in a report on Thursday, October 30th. Finally, Weiss Ratings reissued a “hold (c+)” rating on shares of GE HealthCare Technologies in a research report on Monday, December 29th. Seven equities research analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, GE HealthCare Technologies currently has a consensus rating of “Hold” and a consensus target price of $92.42.

GE HealthCare Technologies Stock Performance

Shares of GEHC opened at $82.31 on Wednesday. The company has a debt-to-equity ratio of 0.91, a current ratio of 1.37 and a quick ratio of 0.95. The stock has a 50-day moving average of $82.72 and a 200-day moving average of $77.50. The company has a market cap of $37.49 billion, a PE ratio of 18.05, a P/E/G ratio of 2.46 and a beta of 1.08. GE HealthCare Technologies has a one year low of $57.65 and a one year high of $94.80.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its quarterly earnings results on Wednesday, February 4th. The company reported $1.44 earnings per share for the quarter, topping analysts’ consensus estimates of $1.40 by $0.04. The business had revenue of $5.70 billion for the quarter, compared to the consensus estimate of $5.60 billion. GE HealthCare Technologies had a return on equity of 21.35% and a net margin of 10.11%.The firm’s revenue for the quarter was up 7.1% on a year-over-year basis. During the same period in the prior year, the business earned $1.45 EPS. GE HealthCare Technologies has set its FY 2026 guidance at 4.950-5.150 EPS. On average, equities research analysts predict that GE HealthCare Technologies will post 4.68 EPS for the current fiscal year.

Institutional Investors Weigh In On GE HealthCare Technologies

A number of institutional investors have recently added to or reduced their stakes in GEHC. CMG Global Holdings LLC increased its stake in GE HealthCare Technologies by 3.3% in the 4th quarter. CMG Global Holdings LLC now owns 17,664 shares of the company’s stock valued at $1,460,000 after buying an additional 559 shares during the last quarter. Mission Wealth Management LP bought a new position in shares of GE HealthCare Technologies in the fourth quarter valued at approximately $204,000. North Dakota State Investment Board purchased a new stake in shares of GE HealthCare Technologies during the fourth quarter valued at approximately $1,288,000. Elyxium Wealth LLC purchased a new stake in shares of GE HealthCare Technologies during the fourth quarter valued at approximately $72,000. Finally, iA Global Asset Management Inc. lifted its holdings in GE HealthCare Technologies by 7.1% during the fourth quarter. iA Global Asset Management Inc. now owns 56,640 shares of the company’s stock worth $4,646,000 after acquiring an additional 3,779 shares during the period. 82.06% of the stock is owned by institutional investors.

Trending Headlines about GE HealthCare Technologies

Here are the key news stories impacting GE HealthCare Technologies this week:

• Positive Sentiment: Q4 results and outlook beat — GEHC reported $1.44 EPS (vs. $1.40 est.) and $5.7B revenue (vs. $5.6B est.), and raised FY‑2026 EPS guidance to $4.95–5.15 (above consensus), a key driver of recent optimism. GE HealthCare reports fourth quarter and full year 2025 financial results
• Positive Sentiment: Evercore ISI raised its price target to $98 with an “outperform” rating ( ~19% upside from current levels), signalling continued analyst confidence after the quarter. Benzinga
• Positive Sentiment: Wells Fargo boosted its PT to $97 and kept an “overweight” rating, citing the stronger results/guidance as support for higher estimates. Benzinga
• Positive Sentiment: BTIG raised its price target to $91 and maintained a “buy” call, another vote of confidence from the sell side after the quarter. GE HealthCare (GEHC) PT Raised to $91 at BTIG
• Neutral Sentiment: Market commentary is bullish on further upside — pieces noting the post‑earnings “pop” argue room remains to run, but they largely reflect sentiment rather than new fundamentals. GE HealthCare Technologies Pops, And The Upside Isn’t Over Yet
• Negative Sentiment: Margin pressure noted — several reports highlight a slide in net margin driven by tariffs and product mix, which tempers the EPS beat and could limit multiple expansion. GE HealthCare Q4 Earnings and Revenues Beat Estimates, Net Margin Falls
• Negative Sentiment: Coverage notes profit fell despite higher revenue — the WSJ and others emphasize the profitability hit, a reminder that growth is not yet fully translating into margin expansion. GE HealthCare Technologies Posts Lower Profit, Despite Higher Revenue

GE HealthCare Technologies Company Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.